// App-Quantinova.ai

OP0163 : 2019 UPDATE OF THE JOINT EUROPEAN LEAGUE AGAINST RHEUMATISM AND EUROPEAN RENAL ASSOCIATION–EUROPEAN DIALYSIS AND TRANSPLANT ASSOCIATION (EULAR/ERA-EDTA) RECOMMENDATIONS FOR THE MANAGEMENT OF LUPUS NEPHRITIS

Researchers

Presenter

  • A. Fanouriakis

Principal Investigators

  • K. Cheema

  • H. J. Anders

  • M. Aringer

  • I. Bajema

  • J. N. Boletis

  • E. Frangou

  • F. Houssiau

  • J. Hollis

  • A. Karras

  • F. Marchiori

  • S. Marks

  • G. Moroni

  • M. Mosca

  • I. Parodis

  • M. Praga

  • M. Schneider

  • J. S. Smolen

  • V. Tesar

  • M. Trachana

  • R. V. Vollenhoven

  • A. Voskuyl

  • Y. K. O. Teng

  • B. Van Leeuw

  • G. Bertsias

  • D. Jayne

  • D. Boumpas

Medical Centers

  • University of Athens, Athens, Greece

  • G. Gennimatas General Hospital, Athens, Greece

  • University of Cambridge, Cambridge, UK

  • University of Munich, Munich, Germany

  • University Hospital Dresden, Dresden, Germany

  • University of Leiden, Leiden, Netherlands

  • Limassol General Hospital, Limassol, Cyprus

  • Universite Catholique de Louvain, Bruxelles, Belgium

  • University of Cambridge, Cambridge, United Kingdom

  • University Paris-Sud, Paris, France

  • Lupus Europe, Rome, Italy

  • Kings College London, London, United Kingdom

  • University of Milan, Milan, Italy

  • University of Pavia, Pavia, Italy

  • Karolinska University Hospital, Stockholm, Sweden

  • Complutense University Madrid, Madrid, Spain,

  • University Hospital, Duesseldorf, Germany

  • Medical University of Vienna, Vienna, Austria

  • Charles Univ and VFN, Prague, Czech Republic

  • Aristotle University of Thessaloniki, Thessaloniki, Greece

  • VU University Medical Center, Amsterdam, Netherlands

  • Lupus Europe, Romford, Essex, United Kingdom

  • University of Crete, Heraklion, Greece

Locations

  • Greece

  • Germany

  • Netherlands

  • Belgium

  • United Kingdom

  • France

  • Italy

  • Sweden

  • Spain

  • Austria

  • Czech Republic

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Autoimmune (AI)

Disease

  • Lupus nephritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • GlaxoSmithKline (GSK)

Result

  • N/A